Prospective Multicenter Validation Confirms the Prognostic Superiority of the Endometrial Carcinoma Prognostic Index in International Federation of Gynecology and Obstetrics Stage 1 and 2 Endometrial Carcinoma

This publication has 31 references indexed in Scilit:

• Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer
  Human Pathology, 2002
• Markers of Proliferative Activity Are Predictors of Patient Outcome for Low-Grade Endometrioid Adenocarcinoma But Not Papillary Serous Carcinoma of Endometrium
  Laboratory Investigation, 2002
• High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI‐2) is an independent marker for shorter progression‐free survival in patients with early stage endometrial cancer
  International Journal of Cancer, 2001
• p53 as a significant prognostic marker in endometrial carcinoma
  International Journal of Gynecologic Cancer, 2000
• Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas
  International Journal of Cancer, 1999
• Angiogenesis in endometrial carcinoma
  Cancer, 1997
• The Prognostic Value of Nuclear Versus Architectural Grading in Endometrial Adenocarcinoma
  International Journal of Gynecological Pathology, 1994
• Prognostic significance of hormone receptors in endometrial cancer
  Cancer, 1993
• Announcements
  Gynecologic Oncology, 1989
• Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma
  Cancer, 1989